v3.25.1

Total revenues - Summary of our main contracts (Details) - EUR (€) | 12 Months Ended
--- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |  |
Period over which to recognize the drug discovery platform revenue | 10 years |  |
Maximum Extension Period For Specific Program | 3 years |  |
Gilead |  |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |  |
Royalties | € 10,604,000 | € 9,466,000 | € 10,726,000

X
- Definition Represents the maximum extension period for specific program. + References No definition available. + Details
Name: | glpg_MaximumExtensionPeriodForSpecificProgram
Namespace Prefix: | glpg_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the period over which the drug discovery program revenue will be recognized. + References No definition available. + Details
Name: | glpg_PeriodOverWhichDrugDiscoveryProgramRevenueIsRecognized
Namespace Prefix: | glpg_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of income arising from royalties. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_RevenueFromRoyalties
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ifrs-full_CounterpartiesAxis=glpg_GileadSciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |